glp-1 liver toxicity GLP-1s are back in the news — but this is a conversation we've explored on our channel before. From weight loss to heart, kidney, liver, sleep and metabolic health, the science is GLP-1 receptor agonists may protect
Description
Lancet 377:13411352 Allison DB, Gadde KM, Garvey WT, Peterson CA, Schwiers ML, Najarian T, Tam PY, Troupin B, Day WW (2012) Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP)
95% CI, 0.48-0.72
Liraglutide promotes the angiogenic ability of human umbilical vein endothelial cells through the JAK2/STAT3 signaling pathway
By acting as molecular sensors and transducers on cell membranes, ion channels, and GPCRs, integrate hormonal, nutritional, and neuronal signals to orchestrate metabolic responses in real time [1,4,5]
Lori Sussel, PhD, associate vice chancellor for basic science at CU Anschutz and research director at the Barbara Davis Center for Diabetes, shared the history and mechanisms of GLP-1s
Many side effects improve once the body adjusts, especially after the first few weeks or when the dose becomes stable
